期刊文献+

精神药物与细胞色素P450 2C酶 被引量:2

Psychotropic Drugs and Cytochrome P450 2C Enzyme
下载PDF
导出
摘要 阿米替林、氯丙咪嗪、西酞普兰、艾司两酞普兰、度洛西汀、吗氯贝胺和苯妥英经2C19酶代谢,氟伏沙明、氟西汀、帕罗西汀和丙戊酸钠抑制2C19酶,理论上升高这些药物血浓度,而卡马西平和苯妥英抑制2C19酶,理论上降低这些药物血浓度。丙戊酸钠、苯妥英、阿戈美拉汀经2C9酶代谢,氟西汀、氟伏沙明、帕罗西汀和丙戊酸钠抑制2C9酶,理论上增加这些药物血浓度,而卡马西平和巴比妥酸盐诱导2C9酶,降低这些药物血浓度。 Amitriptyline, clomipramine, citalopram, escitalopram, duloxetine, moclobemide and phenytoin are metabolized by cytochrome P450 2C19 enzyme, whereas cytochrome P450 2C19 enzyme is inhibited by fluvoxamine, fluoxetine, paroxetine and sodium valproate which can theoretically increase plasma concentrations of the drugs metabolized by cytochrome P450 2C19 enzyme and is induced by carbamazepine and phenytoin which can theoretically decrease plasma concentrations of the drugs also metabolized by cytochrome P450 2C19 enzyme. Sodium valproate, phenytoin and agomelatine are metabolized by cytochrome P450 2C9 enzyme, whereas cytochrome P450 2C9 enzyme is inhibited by fluoxetine, fluvoxamine, paroxetine and sodium valproate which can theoretically increase plasma concentrations of the drugs metabolized by cytochrome P450 2C9 enzyme and is induced by carbamazepine and barbiturate which can theoretically decrease plasma concentrations of the drugs also metabolized by cytochrome P450 2C9 enzyme.
作者 喻东山
出处 《国际老年医学杂志》 2010年第3期120-124,共5页 International Journal of Geriatrics
关键词 细胞色素P450酶 2C19酶 2C9酶 诱导剂 抑制剂 Cytochrome P450 enzyme 2C19 enzyme 2C9 enzyme Inducer Inhibitor
  • 相关文献

参考文献14

  • 1Spina E, Scordo MG, D' Arrigo C. Metabolic drug interaction with new psychotropic agent [ J]. Fundam Clin Pbarmacol, 2003, 17:517 -538.
  • 2Oesterheld JR. A review of developmental aspects of cytochrome P450 [ J]. J Child Adol Psychopharmacology, 1998, 8 (3): 161-174.
  • 3Christensen M, Tybring G, Mibara K, et al. Low daily 10 -mg and 20 -mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome 174501A2 ) and omeprazole (cytochrome P4502C19) [J]. Clin Pharmacol Ther, 2002, 71 (3): 141-152.
  • 4Wojcikowski J, Pichard - Garcia L, Maurel P, et al. The metabolism of the piperazine - type phenothiazine neuroleptic perazine by the human cytochrome P -450 isoenzymes [ J ]. Eur Neuropsychopharmacol, 2004, 14 (3): 199 -208.
  • 5Forget P, de Waroux BP, Wellemacq P, et al. Life -theratening dextromethorphan intoxication associated with interaction with amitriptyline in a poor CYP 2D6 metabolizer : a single case re - exposure study [ J ]. J Pain Symptom Manage, 2008, 36 (1): 92-96.
  • 6Niwa T, Shiraga T, Ishii I, et al. Contribution of human hepatic cytochrome 17450 isoforms to the metabolism of psychotropic drugs [ J ]. Biol Pharm Bull, 2005, 28 (9): 1711 -1716.
  • 7Conus P, Bondolfi G, Eap CB, et al. Pharmacokinetic fluvoxamine - elomipramine interaction with favorable therapeutic consequences in therapy- resistant de- pressive patient [J]. Pharmacopsychiat, 1996, 29: 108 - 110.
  • 8Rudberg I, Reubsaet JL, Hermann M, et al. Identification of a novel CYP2C19 -mediated metabolic pathway of S - citalopram in vitro [ J]. Drug Metab Dispos, 2009, 37 (12): 2340-2348.
  • 9Paris BL, Ogilvie BW, Scheinkoenig JA, et al. In vitro inhibition and induction of human liver eytochrome p450 enzymes by milnacipran [ J]. Drug Metab Dis- pos, 2009, 37 (10): 2045-2054.
  • 10Monaco F, Cicolin A. Interactions between anticonv- ulsant and psychiative drugs [J].Epilepsia, 1999, 40 (Suppl, 10): 71-76.

同被引文献24

  • 1Stauffer VL,Case M,Kimn BJ,et al. Early resix)nse to araipsycl~)tic theray as a clinical marker of subsequent response in the treatment of patients with first-spisode psychosis [ J 1. Psychiatry Res, 2011,187 ( 1 - 2 ) :42 - 48.
  • 2Kion BJ ,Chen L ,Ascher-Svanum H,et al. Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia [ J ]. Schizophrenia Res, 2008,102 (1 -3) :230 -240.
  • 3范肖东,汪向东,许又新,等.ICD-10精神与行为障碍分类:临床描述与诊断要点[M].北京:人民卫生出版社,1993:72—79.
  • 4DavisJM, Chen N, Glick ID. A meta-analysis of the afficacy of second-generation antipsychotics [ J 1- Arch Gen Psychiatry, 2003,60(6) :553 -564.
  • 5Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics [ J ]. Journal Clin Psychiatry, 2003,64 (6) :663 -667.
  • 6喻东山.减分率公式修订[J].临床精神医学杂志,1995,5(1):12.
  • 7Wassef A, Baker J, Kochan LD. GABA and Schizophrenia : A Review of Basic Science and Clinical Studies [ J ]. J Clin Psychopharmacol, 2003,23 (6) :601 - 640.
  • 8Kalkman HO, Loetscher E. GAD (67) : the link between the GABA-deficit hypothesis and the dopaminergic-and glutamatergic theories of psychosis [ J ]. J Neural Transm, 2003,110(7) :803 -812.
  • 9何燕玲,张明园.阳性和阴性综合征量表(PANSS)及其应用[J].临床精神医学杂志,1997,7(6):353-355. 被引量:476
  • 10王锋,江永华.丙戊酸钠辅助治疗难治性精神分裂症的作用[J].临床精神医学杂志,2008,18(4):250-251. 被引量:15

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部